Ablevia biotech GmbH
Injectable peptide-based decoy biotherapeutics that selectively and rapidly remove harmful circulating antibodies from blood.
Adaptable to neutralize vector-specific antibodies in gene therapy and anti-drug antibodies in enzyme/factor replacement therapies (e.g., glycogen storage diseases, hemophilia).
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...
Insights
Loading Insights...
Loading Insight content to display...
Loading Insights...
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...
Funding
Workforce
Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A